{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-037546","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2024-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.275269+00:00","generated_at":"2026-05-31T08:49:44.636464+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"X4 Pharmaceuticals receives Nasdaq deficiency notice for minimum bid price rule; 180 days to regain compliance","bullets":["On Aug 13, 2024, Nasdaq notified X4 that its common stock closing bid price was below $1.00 for 32 consecutive business days.","Company has until Feb 10, 2025 to regain compliance by closing at $1.00+ for ten consecutive days.","If not compliant by Feb 10, X4 may be eligible for additional 180-day cure period if it meets other listing standards.","X4 says it will monitor bid price and consider options including a reverse stock split to cure deficiency.","There is no immediate delisting; stock continues trading under symbol XFOR on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-037546","json":"https://secwatch.observer/filing/0001628280-24-037546.json","markdown":"https://secwatch.observer/filing/0001628280-24-037546.md","text":"https://secwatch.observer/filing/0001628280-24-037546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024037546/0001628280-24-037546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024037546/xfor-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:49:44.636464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}